At Cliantha, we bring extensive expertise in Phase I–IV patient-based clinical trials for investigational new drugs, biologics, and medical devices, delivering high-quality data, regulatory compliance, and seamless project execution. Our capabilities also extend to investigator-initiated studies, rescue studies and orphan drug studies. Our team excels in managing global, multi-center trials across diverse therapeutic areas, ensuring precision and efficiency.

We take a patient-centric approach, leveraging robust site networks, advanced data management systems, and real-world evidence (RWE) methodologies to support regulatory submissions, post-marketing surveillance, and market access strategies.

We offer end-to-end clinical trial solutions, including feasibility assessments, site qualification, patient recruitment, site management, and rigorous study monitoring. Whether delivered through central monitoring, risk-based monitoring, or on-site monitoring, Cliantha ensures seamless execution and optimal outcomes for your clinical development programs.